Product Name

  • Name

    1-Methyl-1-nitrosourea

  • EINECS 211-678-4
  • CAS No. 684-93-5
  • Article Data42
  • CAS DataBase
  • Density 1.46 g/cm3
  • Solubility Soluble. <0.1 g/100 mL at 18 C
  • Melting Point 119-124°C
  • Formula C2H5N3O2
  • Boiling Point 164.3 °C at 760 mmHg
  • Molecular Weight 103.081
  • Flash Point 53.1 °C
  • Transport Information UN 1325 4.1/PG 2
  • Appearance Off-white to pale yellow solid
  • Safety 53-45-24/25-22
  • Risk Codes 45-46-61-11-25
  • Molecular Structure Molecular Structure of 684-93-5 (1-Methyl-1-nitrosourea)
  • Hazard Symbols FlammableF; ToxicT
  • Synonyms 1-methyl-1-nitroso-urea;Urea,1-methyl-1-nitroso- (6CI,8CI);1-Methyl-1-nitrosourea;1-Nitroso-1-methylurea;MNU;Methylnitrosourea;N-Nitroso-N-methylcarbamide;N-Nitroso-N-methylurea;NMH;NMM;NMU;NSC 23909;Nitrosomethylurea;
  • PSA 75.76000
  • LogP 0.37860

Synthetic route

N-Methylurea
598-50-5

N-Methylurea

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With dinitrogen tetroxide impregnated on activated charcoal In dichloromethane at 20℃; for 4h;90%
With cross-linked polyvinylpyrrolidone*N2O4; dinitrogen tetraoxide In dichloromethane at 20℃; for 3.33333h;89%
With hydrogenchloride; sodium nitrite In 2-methyltetrahydrofuran; diethyl ether; water at 25℃; under 6000.6 Torr; for 1.3h; Flow reactor;83%
urea
57-13-6

urea

methylamine
74-89-5

methylamine

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
Stage #1: urea; methylamine With hydrogenchloride In water for 3h; Reflux;
Stage #2: With sodium nitrite at 0 - 20℃;
70%
With hydrogenchloride In water at -15 - 110℃;
1-methylurea nitrite

1-methylurea nitrite

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With sulfuric acid; water at 0℃;51%
N-acetyl-N'-methylurea
623-59-6

N-acetyl-N'-methylurea

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite
Stage #1: N-acetyl-N'-methylurea With hydrogenchloride at 100℃; for 0.0666667h;
Stage #2: With sodium nitrite cooling; Further stages.;
8 g
Stage #1: N-acetyl-N'-methylurea With hydrogenchloride In water at 100℃; for 0.2h;
Stage #2: With sodium nitrite In water Cooling with ice;
9 g
potassium cyanate
590-28-3

potassium cyanate

methylamine hydrochloride
593-51-1

methylamine hydrochloride

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

methylamine hydrochloride
593-51-1

methylamine hydrochloride

urea
57-13-6

urea

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With water bei Siedetemperatur und anschliessende Umsetzung mit NaNO2 und verd. H2SO4 unter Kuehlung;
Stage #1: methylamine hydrochloride; urea In water at 105℃; for 3.5h;
Stage #2: With sodium nitrite In water at 40℃; for 0.25h;
Stage #3: With sulfuric acid In tetrahydrofuran; water at 0 - 5℃; for 2h;
Stage #1: methylamine hydrochloride; urea In water at 105℃; for 3.5h;
Stage #2: With sodium nitrite In water at 40℃; for 0.25h;
Methylnitrosocyanamid
33868-17-6

Methylnitrosocyanamid

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With sulfuric acid In dichloromethane
nitrate methylurea

nitrate methylurea

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
With water; sodium nitrite
water
7732-18-5

water

methyluronium nitrate
598-11-8

methyluronium nitrate

sodium nitrite

sodium nitrite

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

acetamide
60-35-5

acetamide

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Conditions
ConditionsYield
Stage #1: acetamide With bromine; sodium hydroxide In water at 100℃;
Stage #2: With hydrogenchloride at 100℃; for 0.002h;
Stage #3: With sodium nitrite In water Cooling with ice;
9 g
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

dikegulac
18467-77-1

dikegulac

methyl 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonate
52507-90-1

methyl 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonate

Conditions
ConditionsYield
With potassium hydroxide 1.) ether, ice-bath cooling, 2 min, 2.) methanol, gently warming;100%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

(R)-Mandelic Acid
611-71-2

(R)-Mandelic Acid

(R)-methyl mandelate
20698-91-3

(R)-methyl mandelate

Conditions
ConditionsYield
With potassium hydroxide In diethyl ether; water at 0℃; for 0.25h;100%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

1-adamantylacetyl chloride
19835-38-2

1-adamantylacetyl chloride

1-diazo-3-(1-adamantyl)-2-propanone
27174-66-9

1-diazo-3-(1-adamantyl)-2-propanone

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.25h; Inert atmosphere;
Stage #2: 1-adamantylacetyl chloride In diethyl ether at 0 - 20℃; Inert atmosphere;
100%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate
1513-60-6

ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate

4-ethoxycarbonyl-3,3-bis(trifluoromethyl)-2-pyrazoline
390388-85-9

4-ethoxycarbonyl-3,3-bis(trifluoromethyl)-2-pyrazoline

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃;
Stage #2: ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate In diethyl ether at 20℃; for 1h;
99%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Nα-phthaloyl-L-phenylalanine
5123-55-7

Nα-phthaloyl-L-phenylalanine

(S)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoate
14380-85-9

(S)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoate

Conditions
ConditionsYield
With potassium hydroxide In diethyl ether; water99%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

3-(benzofuran-2-yl)isoxazol-5(4H)-one

3-(benzofuran-2-yl)isoxazol-5(4H)-one

3-(benzofuran-2-yl)-5-methoxyisoxazole

3-(benzofuran-2-yl)-5-methoxyisoxazole

Conditions
ConditionsYield
With potassium hydroxide In diethyl ether; water for 0.5h;99%
(E)-4,4,5,5-tetramethyl-2-(3-methylbut-1-en-1-yl)-1,3,2-dioxaborolane
177949-92-7

(E)-4,4,5,5-tetramethyl-2-(3-methylbut-1-en-1-yl)-1,3,2-dioxaborolane

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

rac-trans-2-[2-isopropylcyclopropyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

rac-trans-2-[2-isopropylcyclopropyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water for 0.0833333h; Cooling with ice;
Stage #2: (E)-4,4,5,5-tetramethyl-2-(3-methylbut-1-en-1-yl)-1,3,2-dioxaborolane With palladium diacetate In diethyl ether; water Cooling with ice;
99%
With palladium diacetate; potassium hydroxide In diethyl ether; water at 20℃;99%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

spiro<2.4>hepta-4,6-diene 2,6>deca-3,8-diene)-10-spirocyclopropane>
36911-54-3

spiro<2.4>hepta-4,6-diene 2,6>deca-3,8-diene)-10-spirocyclopropane>

dispiro2,6.08,10>undec-4-ene-12',1''-cyclopropane>
139537-61-4

dispiro2,6.08,10>undec-4-ene-12',1''-cyclopropane>

Conditions
ConditionsYield
With potassium hydroxide; bis(benzonitrile)palladium(II) dichloride In dichloromethane at 10℃; for 0.333333h;98%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

undecacyclo[10.9.0.01,5.02,13.02,19.03,7.06,11.08,13.012,16.014,18.017,21]henicosane-4-anti-carboxylic acid

undecacyclo[10.9.0.01,5.02,13.02,19.03,7.06,11.08,13.012,16.014,18.017,21]henicosane-4-anti-carboxylic acid

methyl undecacyclo[10.9.0.01,5.02,13.02,19.03,7.06,11.08,13.012,16.014,18.017,21]henicosane-4-anti-carboxylate

methyl undecacyclo[10.9.0.01,5.02,13.02,19.03,7.06,11.08,13.012,16.014,18.017,21]henicosane-4-anti-carboxylate

Conditions
ConditionsYield
With potassium hydroxide In diethyl ether; dichloromethane; water for 2h;98%
norborn-2-ene
498-66-8

norborn-2-ene

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

exo-3,4-diazatricyclo[5.2.1.02,6]dec-3-ene
5744-22-9

exo-3,4-diazatricyclo[5.2.1.02,6]dec-3-ene

Conditions
ConditionsYield
With potassium hydroxide In diethyl ether; water at -5℃; for 1h;98%
2-But-2-ynyl-2-[(E)-3-((1S,2R)-2-carboxy-cyclopropyl)-allyl]-malonic acid dimethyl ester

2-But-2-ynyl-2-[(E)-3-((1S,2R)-2-carboxy-cyclopropyl)-allyl]-malonic acid dimethyl ester

1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

dimethyl trans-2-but-2-ynyl-2-[3-(2-methoxycarbonyl-cyclopropyl)-allyl]-malonate

dimethyl trans-2-but-2-ynyl-2-[3-(2-methoxycarbonyl-cyclopropyl)-allyl]-malonate

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water at 0℃;
Stage #2: 2-But-2-ynyl-2-[(E)-3-((1S,2R)-2-carboxy-cyclopropyl)-allyl]-malonic acid dimethyl ester In diethyl ether Further stages.;
98%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

C28H28O12S2

C28H28O12S2

C29H30O12S2

C29H30O12S2

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide
Stage #2: C28H28O12S2
98%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid
58650-92-3

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium hydroxide In methanol at -20℃;97%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

1-(1-fluorovinyl)-1-methylcyclopropane
760179-31-5

1-(1-fluorovinyl)-1-methylcyclopropane

1-fluoro-1-(1-methylcyclopropyl)cyclopropane

1-fluoro-1-(1-methylcyclopropyl)cyclopropane

Conditions
ConditionsYield
With potassium hydroxide; palladium(II) acetylacetonate In dichloromethane; pentane97%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester
182156-01-0

2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester

2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester 4-methyl ester
182156-02-1

2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester 4-methyl ester

Conditions
ConditionsYield
With triethylamine In various solvent(s) for 48h; Ambient temperature;96%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

(4R,7S,9S,E)-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoic acid

(4R,7S,9S,E)-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoic acid

(4R,7S,9S,E)-methyl-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoate

(4R,7S,9S,E)-methyl-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoate

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.166667h;
Stage #2: (4R,7S,9S,E)-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoic acid In diethyl ether for 0.166667h;
96%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

dimethyl acetylenedicarboxylate
762-42-5

dimethyl acetylenedicarboxylate

triphenylphosphine
603-35-0

triphenylphosphine

dimethyl 2-(methyl{[(nitrosomethyl)amino]carbonyl}amino)-3-(1,1,1-triphenyl-λ5-phosphanylidene)succinate

dimethyl 2-(methyl{[(nitrosomethyl)amino]carbonyl}amino)-3-(1,1,1-triphenyl-λ5-phosphanylidene)succinate

Conditions
ConditionsYield
In hexane; ethyl acetate at 20℃; for 1.5h;95%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine
18942-46-6

N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

[(R)-3-diazo-1-(4-methoxy-benzylsulfanylmethyl)-2-oxo-propyl]-carbamic acid tert-butyl ester
1120344-81-1

[(R)-3-diazo-1-(4-methoxy-benzylsulfanylmethyl)-2-oxo-propyl]-carbamic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine; chloroformic acid ethyl ester With 4-methyl-morpholine In tetrahydrofuran at -25℃; for 1h;
Stage #2: 1-methyl-1-nitrosourea With potassium hydroxide In tetrahydrofuran; diethyl ether; water at -25 - 20℃; for 3h;
95%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

Lapachol
84-79-7

Lapachol

2-methoxylapachol
17241-45-1

2-methoxylapachol

Conditions
ConditionsYield
With potassium hydroxide at 0℃; Inert atmosphere;95%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

5-bromo-1-nitro-2-propoxy-3-vinylbenzene

5-bromo-1-nitro-2-propoxy-3-vinylbenzene

5-bromo-1-cyclopropyl-3-nitro-2-propoxybenzene

5-bromo-1-cyclopropyl-3-nitro-2-propoxybenzene

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With sodium hydroxide In diethyl ether; water at 0℃; for 0.25h;
Stage #2: 5-bromo-1-nitro-2-propoxy-3-vinylbenzene With palladium diacetate In diethyl ether; dichloromethane at 0℃; for 1h;
95%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

amphidinin B
914257-11-7

amphidinin B

dimethyl ester of amphidinin B
1269803-21-5

dimethyl ester of amphidinin B

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With sodium hydroxide In water
Stage #2: amphidinin B In diethyl ether at 0℃; Inert atmosphere;
94%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

tert-butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate
203661-69-2

tert-butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate

tert-butyl 2-oxo-8-azaspiro[4.5]decane-8-carboxylate
1250994-14-9

tert-butyl 2-oxo-8-azaspiro[4.5]decane-8-carboxylate

Conditions
ConditionsYield
With potassium hydroxide In 2-methyltetrahydrofuran; methanol93%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoic acid
634606-12-5

4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoic acid

methyl 4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoate
634606-13-6

methyl 4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoate

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.166667h;
Stage #2: 4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoic acid In methanol; diethyl ether for 0.166667h;
90%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

(R)-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoic acid
1371608-84-2

(R)-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoic acid

(R)-methyl-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoate
1371608-85-3

(R)-methyl-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoate

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether
Stage #2: (R)-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoic acid In tetrahydrofuran; diethyl ether at 0℃; for 1h;
90%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

2,3-diethyl-7-isobutyl-8-methyl-(10H)-dipyrrin-1-one-9-carboxylic acid

2,3-diethyl-7-isobutyl-8-methyl-(10H)-dipyrrin-1-one-9-carboxylic acid

2,3-diethyl-7-isobutyl-8-methyl-9-carbomethoxy-(10H)-dipyrrin-1-one

2,3-diethyl-7-isobutyl-8-methyl-9-carbomethoxy-(10H)-dipyrrin-1-one

Conditions
ConditionsYield
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water at 0℃;
Stage #2: 2,3-diethyl-7-isobutyl-8-methyl-(10H)-dipyrrin-1-one-9-carboxylic acid In methanol; diethyl ether; water at 20℃; for 0.583333h;
90%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

4-chloro-N-({4-chloro-3-[(3-cyano-5-ethenylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide
1093262-44-2

4-chloro-N-({4-chloro-3-[(3-cyano-5-ethenylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide

4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide
1093262-46-4

4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide

Conditions
ConditionsYield
With potassium hydroxide; palladium diacetate In diethyl ether; dichloromethane; water at 0℃; for 1h;90%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

1,1,2,2-tetrafluoro-3-vinylcyclobutane
356-77-4

1,1,2,2-tetrafluoro-3-vinylcyclobutane

3-cyclopropyl-1,1,2,2-tetrafluorocyclobutane

3-cyclopropyl-1,1,2,2-tetrafluorocyclobutane

Conditions
ConditionsYield
With palladium(II) acetylacetonate In potassium hydroxide; dichloromethane at 5 - 8℃;89%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

2-chloro-1,1,2-trifluoro-3-vinylcyclobutane
697-14-3

2-chloro-1,1,2-trifluoro-3-vinylcyclobutane

2-chloro-3-cyclopropyl-1,1,2-trifluorocyclobutane

2-chloro-3-cyclopropyl-1,1,2-trifluorocyclobutane

Conditions
ConditionsYield
With palladium(II) acetylacetonate In potassium hydroxide; dichloromethane; pentane at 5 - 8℃;89%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

4-(prop-2-yn-1-yl)-3-(quinolin-2-yl)isoxazol-5-ol

4-(prop-2-yn-1-yl)-3-(quinolin-2-yl)isoxazol-5-ol

5-methoxy-4-(prop-2-yn-1-yl)-3-(quinolin-2-yl)isoxazole

5-methoxy-4-(prop-2-yn-1-yl)-3-(quinolin-2-yl)isoxazole

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran; diethyl ether; water89%

N-Nitroso-N-methylurea Consensus Reports

NTP 10th Report on Carcinogens. IARC Cancer Review: Group 2A IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 227.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 227.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) , IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 ,1972,p. 125.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program. Community Right-To-Know List. Reported in EPA TSCA Inventory.

N-Nitroso-N-methylurea Specification

N-Methyl-N-nitrosourea(CAS NO.684-93-5) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids. It is used as precursor of diazomethane. It has a cytotoxicity effect. This product contains an undetermined amount of water. N-Methyl-N-nitrosourea is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation.

Physical properties about N-Nitroso-N-methylurea are: (1)ACD/LogP: -0.302; (2)ACD/LogD (pH 5.5): -0.30; (3)ACD/LogD (pH 7.4): -0.30; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 16.32; (7)ACD/KOC (pH 7.4): 16.32; (8)#H bond acceptors: 5; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 1; (11)Index of Refraction: 1.545; (12)Molar Refractivity: 22.2 cm3; (13)Molar Volume: 70.241 cm3; (14)Polarizability: 8.801 10-24cm3; (15)Surface Tension: 61.148998260498 dyne/cm; (16)Density: 1.468 g/cm3; (17)Flash Point: 53.143 °C; (18)Enthalpy of Vaporization: 40.078 kJ/mol; (19)Boiling Point: 164.26 °C at 760 mmHg; (20)Vapour Pressure: 1.98300004005432 mmHg at 25°C

When you are using this chemical, please be cautious about it as the following:
1. Avoid exposure - obtain special instruction before use;
2. In case of accident or if you feel unwell, seek medical advice immediately (show label where possible);
3. Avoid contact with skin and eyes;
4. Do not breathe dust;

You can still convert the following datas into molecular structure:
(1)InChI=1S/C2H5N3O2/c1-5(4-7)2(3)6/h1H3,(H2,3,6);
(2)InChIKey=ZRKWMRDKSOPRRS-UHFFFAOYSA-N;
(3)SmilesN(C(N)=O)(N=O)C

 The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
hamster LD50 subcutaneous 113mg/kg (113mg/kg)   British Journal of Cancer. Vol. 29, Pg. 359, 1974.
 
hamster LDLo intravenous 42mg/kg (42mg/kg)   Journal of Pathology and Bacteriology. Vol. 92, Pg. 35, 1966.
 
mammal (species unspecified) LD50 intravenous 110mg/kg (110mg/kg)   Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975.
mammal (species unspecified) LD50 oral 110mg/kg (110mg/kg)   Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975.
mouse LD50 intraperitoneal 144mg/kg (144mg/kg)   Cancer Research. Vol. 30, Pg. 11, 1970.
 
rat LD50 intraperitoneal 110mg/kg (110mg/kg)   Nature. Vol. 222, Pg. 1064, 1969.
 
rat LD50 intravenous 108mg/kg (108mg/kg)   Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. Vol. 257, Pg. 296, 1967.
rat LD50 oral 110mg/kg (110mg/kg)   Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967.
 
rat LDLo implant 30mg/kg (30mg/kg) KIDNEY, URETER, AND BLADDER: OTHER CHANGES Chemico-Biological Interactions. Vol. 5, Pg. 139, 1972.
 

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View